Publications by authors named "Roberto Spyridon Bringiotti"
Article Synopsis
- Interferon-based therapies for HCV recurrence after liver transplantation have been largely ineffective and face safety issues with other treatments like boceprevir and telaprevir.
- A study assessed the efficacy and safety of intravenous silibinin in 20 patients who did not respond to previous treatments; patients were randomly assigned to receive either silibinin or placebo.
- Results showed that silibinin significantly reduced viral load after 14 days of treatment, was well tolerated with only minor side effects, and did not require adjustments to immunosuppressive medication levels.
